Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.50 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.49 |
| ▸ | GFER | P55789 | 2/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.48 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7282073 | 0.98 | CYP4F2 (0.49) | CYP4F2CYP4A11F2RL1GFERADRB2 | |
| Sulfuric Acid SCHEMBL4181579 | 0.93 | IDO1 (0.49) | CYP4F2CYP4A11F2RL1GFERADRB2 | |
| SCHEMBL22922181 | 0.90 | CYP4F2 (0.59) | CYP4F2CYP4A11F2RL1ADRB2ADRB1 | |
| SCHEMBL1351101 | 0.89 | TSHR (0.48) | CYP4F2CYP4A11GFERCYP19A1EPHX2 | |
| SCHEMBL1745141 | 0.87 | FFAR1 (0.58) | ADRB2ADRB1ALDH1A1MAPTHTT | |
| Hydrochloric Acid SCHEMBL1789073 | 0.87 | MAOB (0.47) | CYP4F2CYP4A11GFERCYP19A1EPHX2 | |
| SCHEMBL9689657 | 0.87 | MAOB (0.48) | CYP4F2CYP4A11EPHX2TSHR | |
| SCHEMBL28813051 | 0.87 | F2RL1 (0.57) | CYP4F2CYP4A11F2RL1GFERCYP19A1 | |
| Hydrochloric Acid SCHEMBL9265296 | 0.87 | TAAR1 (0.50) | CYP4F2CYP4A11F2RL1ADRB2ADRB1 | |
| SCHEMBL23200335 | 0.86 | HPGD (0.49) | CYP4F2CYP4A11EPHX2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3099728-A1 | COPOLYMER OF A BISPHENOL DIGLYCIDYL ETHER AND A PHENOLPHTHALENE AND/OR A PHENOLPHTHALIMIDINE, METHOD FOR THE PREPARATION THEREOF, ARTICLE COMPRISING THE COPOLYMER, AND COMPOSITIONS COMPRISING THE COPOLYMER | SABIC Global Technologies B.V. (NL) | 2016-12-07 | — | — | EP | claimed |
| EP-2951226-A1 | TRIBLOCK COPOLYMER, METHOD FOR ITS FORMATION, AND COMPATIBILIZED COMPOSITIONS COMPRISING IT | SABIC Global Technologies B.V. (NL) | 2015-12-09 | — | — | EP | claimed |
| WO-2015116349-A1 | COPOLYMER OF A BISPHENOL DIGLYCIDYL ETHER AND A PHENOLPHTHALENE AND/OR A PHENOLPHTHALIMIDINE, METHOD FOR THE PREPARATION THEREOF, ARTICLE COMPRISING THE COPOLYMER, AND COMPOSITIONS COMPRISING THE COPOLYMER | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-08-06 | — | — | WO | claimed |
| US-20150210806-A1 | COPOLYMER OF A BISPHENOL DIGLYCIDYL ETHER AND A PHENOLPHTHALENE AND/OR A PHENOLPHTHALIMIDINE, METHOD FOR THE PREPARATION THEREOF, ARTICLE COMPRISING THE COPOLYMER, AND COMPOSITIONS COMPRISING THE COPOLYMER | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2015-07-30 | — | — | US | claimed |
| EP-2822998-A1 | COMPATIBILIZED COMPOSITION, METHOD FOR THE FORMATION THEREOF, AND ARTICLE COMPRISING SAME | SABIC Innovative Plastics IP B.V. (NL) | 2015-01-14 | — | — | EP | claimed |
| US-8865823-B2 | Triblock copolymer, method for its formation, and compatibilized compositions comprising it | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2014-10-21 | — | — | US | claimed |
| US-20140221552-A1 | TRIBLOCK COPOLYMER, METHOD FOR ITS FORMATION, AND COMPATIBILIZED COMPOSITIONS COMPRISING IT | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2014-08-07 | — | — | US | claimed |
| WO-2014120650-A1 | TRIBLOCK COPOLYMER, METHOD FOR ITS FORMATION, AND COMPATIBILIZED COMPOSITIONS COMPRISING IT | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2014-08-07 | — | — | WO | claimed |
| US-8552105-B2 | Compatibilized composition, method for the formation thereof, and article comprising same | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2013-10-08 | — | — | US | claimed |
| US-20130237648-A1 | COMPATIBILIZED COMPOSITION, METHOD FOR THE FORMATION THEREOF, AND ARTICLE COMPRISING SAME | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2013-09-12 | — | — | US | claimed |
| WO-2013133878-A1 | COMPATIBILIZED COMPOSITION, METHOD FOR THE FORMATION THEREOF, AND ARTICLE COMPRISING SAME | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2013-09-12 | — | — | WO | claimed |
| WO-2025122555-A1 | S1P 1 RECEPTOR AGONISTS AND USES THEREOF | VALO HEALTH, INC. (US) | 2025-06-12 | — | — | WO | disclosed |
| US-20250066364-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | BIAL R&D INVEST S A (PT) | 2025-02-27 | — | — | US | disclosed |
| US-20240398776-A1 | INHIBITORS OF TGF-BETA R1 (ALK5) USEFUL TO TREAT CELL PROLIFERATION DISORDERS | NEXYS THERAPEUTICS, INC. (US) | 2024-12-05 | — | — | US | disclosed |
| WO-2024211969-A1 | PPARG MODULATORS | Setonix Pharmaceuticals Pty Ltd (AU) | 2024-10-17 | — | — | WO | disclosed |
| CN-1048039-A | Imidazolyl-alkenoic acids | SMITHKLINE BEECHAM CORP (US) | 1990-12-26 | — | — | CN | disclosed |
| EP-0271099-A2 | Substituted aminopropionic acid amides, process for their preparation, agents containing them and their use as well as the intermediates formed during the preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-06-15 | — | — | EP | disclosed |
| US-4456668-A | DYE BLEACH, TEXTILE DYES | CIBA GEIGY AG (CH) | 1984-06-26 | — | — | US | disclosed |
| US-4409143-A | TEXTILES, PHOTOGRAPHY | CIBA-GEIGY AG (CH) | 1983-10-11 | — | — | US | disclosed |
| US-4379819-A | OIL SOLUBLE MONOAZO DYE | CIBA-GEIGY AG (CH) | 1983-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240398776-A1 | INHIBITORS OF TGF-BETA R1 (ALK5) USEFUL TO TREAT CELL PROLIFERATION DISORDERS | ACVR1, TGFBR1, ACVRL1 | CYP4F2 4382/4885CYP4A11 2756/4885F2RL1 385/4885 |
| US-20250066364-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | PARK7, PNP, GAA | CYP4F2 3971/4885CYP4A11 2403/4885F2RL1 4027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.